Circulating Conventional and Plasmacytoid Dendritic Cell Subsets Display Distinct Kinetics during In Vivo Repeated Allergen Skin Challenges in Atopic Subjects

• Published in: BioMed research international 2014-01, Vol.2014 (2014), p.1-14
• Main Authors: Xanthou, Georgina, Gaga, Mina, Vittorakis, Stelios, Panoutsakopoulou, Vily, Semitekolou, Maria, Aggelakopoulou, Maria, Samitas, Konstantinos, Tousa, Sofia, Zervas, Eleftherios
• Format: Article
• Language: English
• Subjects: Activins - blood; Activins - immunology; Adolescent; Adult; Allergens - toxicity; Allergies; Aqueous solutions; Asthma; Atopic dermatitis; Biomedical research; Chemokines; Clinical Study; Cytokines; Dendritic cells; Dendritic Cells - immunology; Dendritic Cells - metabolism; Dendritic Cells - pathology; Dermatitis, Atopic - blood; Dermatitis, Atopic - immunology; Dermatitis, Atopic - pathology; Female; Gene Expression Regulation - drug effects; Gene Expression Regulation - immunology; Genetic aspects; Health aspects; Humans; Immune system; Inflammation - blood; Inflammation - immunology; Inflammation - pathology; Lymphocytes; Male; Middle Aged; Migration; Plasma Cells - immunology; Plasma Cells - metabolism; Plasma Cells - pathology; Receptors, CCR10 - blood; Receptors, CCR10 - immunology; Receptors, CCR4 - blood; Receptors, CCR4 - immunology; Risk factors; Skin - immunology; Skin - metabolism; Skin - pathology; Skin Tests; Studies
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2014/231036

Upon allergen challenge, DC subsets are recruited to target sites under the influence of chemotactic agents; however, details pertinent to their trafficking remain largely unknown. We investigated the kinetic profiles of blood and skin-infiltrating DC subsets in twelve atopic subjects receiving six weekly intradermal allergen and diluent injections. The role of activin-A, a cytokine induced in allergic and tissue repair processes, on the chemotactic profiles of DC subsets was also examined. Plasmacytoid (pDCs) and conventional DCs (cDCs) were evaluated at various time-points in the blood and skin. In situ activin-A expression was assessed in the skin and its effects on chemokine receptor expression of isolated cDCs were investigated. Blood pDCs were reduced 1 h after challenge, while cDCs decreased gradually within 24 h. Skin cDCs increased significantly 24 h after the first challenge, inversely correlating with blood cDCs. Activin-A in the skin increased 24 h after the first allergen challenge and correlated with infiltrating cDCs. Activin-A increased the CCR10/CCR4 expression ratio in cultured human cDCs. DC subsets demonstrate distinct kinetic profiles in the blood and skin especially during acute allergic inflammation, pointing to disparate roles depending on each phase of the inflammatory response. The effects of activin-A on modulating the chemotactic profile of cDCs suggest it may be a plausible therapeutic target for allergic diseases.